Summary
The bioavailability of metoprolol was studied in eight healthy young and seven healthy elderly volunteers. Large interindividual differences in the bioavailability of metoprolol were observed in both groups. However, there was no significant difference in AUC, peak plasma concentration or elimination half-life between young and elderly, but time to peak concentration was significantly longer in the elderly. Pretreatment with metoclopramide had no effect on AUC but caused significant increases in peak concentration and decreases in time to peak concentration in both groups. Probanthine pretreatment (only to the young) resulted in a significant decrease in peak concentration of metoprolol and a significant increase in time to peak concentration but had no effect on the AUC. These results suggest that alterations in gastric emptying and gut motility due to ageing or other drugs have no effect on the overall availability of metoprolol to the systemic circulation but may have significant effects on the time to peak plasma concentration and peak concentration achieved after a single oral dose.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bender AD (1968) Effect of age on intestinal absorption: Implications for drug absorption in the elderly. J Am Geriatr Soc 60: 1331–1339
Gibbons DO, Lant AF (1975) Effects of intravenous and oral propantheline and metoclopramide on ethanol absorption. Clin Pharmacol Ther 17: 578–584
Grundin R, Moldeus P, Orrenuis S, Borg KO, Skanberg I, von Bahr C (1974) The possible role of cytochrome P-450 in the liver ‘first pass elimination’ ofβ-receptor blocking drug. Acta Pharmacol Toxicol 35: 242–260
Johansson R, Regardh C-G, Sjögren J (1971) Absorption of alprenolol in man from tablets with different rates of release. Acta Pharm Suec 8: 59–70
Johnsson G, Regardh C-G (1976) Clinical pharmacokinetics ofβ-adrenoceptor blocking drugs. Clin Pharmacokinet 1: 233–263
Kendall MJ, Brown D, Yates RA (1977) Plasma metoprolol concentrations in young, old and hypertensive subjects. Br J Clin Pharmacol 4: 497–499
Lennard MS, Silas JH, Freestone S, Trevethick J (1982) Defective metabolism of metoprolol in poor hydroxylators of debrisoquine. Br J Clin Pharmacol 14: 301–303
Nimmo J, Heading RC, Tothill P, Prescott LF (1973) Pharmacological modification of gastric emptying: Effects of propantheline and metoclopramide on paracetamol absorption. Br Med J 1: 587–589
Quarterman CP, Kendall MJ, Jack DB (1981) The effect of age on the pharmacokinetics of metoprolol and its metabolites. Br J Clin Pharmacol 11: 287–294
Routledge PA, Shand DG (1979) Clinical pharmacokinetics of propranolol. Clin Pharmacokinet 4: 73–90
Shand DG, Rangno RE (1972) The disposition of propranolol. I Elimination during oral absorption in man. Pharmacology 7: 147–168
Shand DG, Branch RA, Evans GH, Nies AS, Wilkinson GR (1973) The disposition of propranolol. VII The effects of saturable hepatic tissue uptake on drug clearance by the perfused rat liver. Drug Metab Dispos 1: 679–686
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Briant, R.H., Dorrington, R.E., Ferry, D.G. et al. Bioavailability of metoprolol in young adults and the elderly, with additional studies on the effects of metoclopramide and probanthine. Eur J Clin Pharmacol 25, 353–356 (1983). https://doi.org/10.1007/BF01037947
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01037947